STING-ATF3/type I interferon crosstalk: A potential target to improve anti-tumour immunity in chemotherapy-treated urothelial carcinoma.

Alexandra FauvreMargot MachuAudrey MerienneNadia VieThomas BessedeMathilde RobinVeronique GaramboisClara TaffoniNadine LaguetteNadine Gervois-SegainAnne JarryNathalie LabarriereYves AlloryChristel LarbouretLaurent GrosDiego TosiDavid B SolitPhilippe PourquierNadine HouédéCéline Gongora

Published in: Clinical and translational medicine (2024)

Keyphrases

transcription factor
dendritic cells
endoplasmic reticulum stress
locally advanced
human health
radiation therapy
immune response
risk assessment